Literature DB >> 9851550

Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata.

M R Weed1, W L Woolverton, I A Paul.   

Abstract

Several phenyl-benzazepine compounds, putatively selective dopamine D1 receptor agonists, have been used to study the effects of dopamine D1 receptor stimulation in rodents and nonhuman primates. However, the dopamine receptor selectivities of these compounds have not been established in nonhuman primates. Accordingly, the relative selectivities of six phenyl-benzazepines for dopamine D1-like and D2-like receptors were assessed in rhesus monkey and, for comparison, rat striata. The compounds tested had higher affinity for D1 than D2 receptors in both species; however, their selectivity varied by up to three orders of magnitude. GTP (100 microM) reduced agonist binding at the high-affinity state of the dopamine D1 receptor, but the magnitude of the effect of GTP did not reliably predict a compound's efficacy. Furthermore, a history of cocaine self-administration did not appear to influence dopamine receptor binding characteristics in the rhesus monkeys in this study. The present results will aid the comparison of dopamine receptor binding characteristics and behavioral effects of D1 dopamine receptor agonists.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851550     DOI: 10.1016/s0014-2999(98)00669-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Review. Positron emission tomography imaging studies of dopamine receptors in primate models of addiction.

Authors:  Michael A Nader; Paul W Czoty; Robert W Gould; Natallia V Riddick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 2.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

3.  Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

Authors:  Sunmee Wee; Zhixia Wang; William L Woolverton; Luigi Pulvirenti; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

4.  Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.

Authors:  Robert W Gould; Linda J Porrino; Michael A Nader
Journal:  Curr Top Behav Neurosci       Date:  2012

5.  fMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia.

Authors:  Joseph B Mandeville; Ji-Kyung Choi; Bechir Jarraya; Bruce R Rosen; Bruce G Jenkins; Wim Vanduffel
Journal:  Neuropsychopharmacology       Date:  2011-02-09       Impact factor: 7.853

6.  Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates.

Authors:  Taline V Khroyan; Donna M Platt; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

7.  A receptor-based model for dopamine-induced fMRI signal.

Authors:  Joseph B Mandeville; Christin Y M Sander; Bruce G Jenkins; Jacob M Hooker; Ciprian Catana; Wim Vanduffel; Nathaniel M Alpert; Bruce R Rosen; Marc D Normandin
Journal:  Neuroimage       Date:  2013-03-01       Impact factor: 6.556

Review 8.  Computer-aided Drug Design Applied to Parkinson Targets.

Authors:  Hamilton M Ishiki; Jose Maria Barbosa Filho; Marcelo S da Silva; Marcus T Scotti; Luciana Scotti
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.